Inhibition of Glutamate Carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis

Half of all patients with multiple sclerosis (MS) experience cognitive impairment, for which there is no pharmacological treatment. Using magnetic resonance spectroscopy (MRS), we examined metabolic changes in the hippocampi of MS patients, compared the findings to performance on a neurocognitive te...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Rahn, Kristen A., Watkins, Crystal C., Alt, Jesse, Rais, Rana, Stathis, Marigo, Grishkan, Inna, Crainiceau, Ciprian M., Pomper, Martin G., Rojas, Camilo, Pletnikov, Mikhail V., Calabresi, Peter A., Brandt, Jason, Barker, Peter B., Slusher, Barbara S., Kaplin, Adam I.
Formato: Artigo
Idioma:Inglês
Publicado em: National Academy of Sciences 2012
Assuntos:
Biological Sciences
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3523869/
https://ncbi.nlm.nih.gov/pubmed/23169655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1209934109
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados